Showing results (1311-1320 of 1,366) with videos related to

Sort By:
Pageof 137
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2011
Iroquois homeobox gene 3 establishes fast conduction in the cardiac His-Purkinje networkShan-Shan Zhang, Kyoung-Han Kim, Anna Rosen, et al.
Frontiers in Neural Circuits|June 26, 2026
A modular and flexible pipeline for intraoperative electrode reconstruction and localization in patients with brain lesionsHaziq Rabbani, Ipsita Das, Ayan S Mandal, et al.
Pigment Cell & Melanoma Research|October 17, 2013
Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanomaR Mark Simpson, Boris C Bastian, Helen T Michael, et al.
Toxins|November 26, 2024
Aerosolized Harmful Algal Bloom Toxin Microcystin-LR Induces Type 1/Type 17 Inflammation of Murine AirwaysJoshua D Breidenbach, Benjamin W French, Lauren M Stanoszek, et al.
Nature Genetics|October 4, 2022
Gain-of-function mutations in KCNK3 cause a developmental disorder with sleep apneaJanina Sörmann, Marcus Schewe, Peter Proks, et al.
Transplantation Direct|March 11, 2024
Single-center Outcomes After Liver Transplantation With SARS-CoV-2-Positive Donors: An Argument for Increased UtilizationAshton A Connor, Max W Adelman, Constance M Mobley, et al.
Regulatory Toxicology and Pharmacology : RTP|March 2, 2016
Micro-CT imaging: Developing criteria for examining fetal skeletons in regulatory developmental toxicology studies - A workshop reportHoward M Solomon, Susan L Makris, Hasan Alsaid, et al.
Cancer Letters|June 25, 2023
Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myelomaTyler J Peat, Snehal M Gaikwad, Wendy Dubois, et al.
Human Genetics|March 25, 2024
Heterozygous loss-of-function variants in DOCK4 cause neurodevelopmental delay and microcephalyCharlotte Herbst, Viktoria Bothe, Meret Wegler, et al.
Journal of the American Heart Association|March 26, 2025
Methylated Arginine Metabolites as Biomarkers for Clinical Status and Response to Type 5 Phosphodiesterase Inhibition in Patients With Fontan CirculationAri Cedars, Cedric Manlhiot, Bhargava Kumar Chinni, et al.
Pageof 137